647 related articles for article (PubMed ID: 9388153)
1. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.
Cromwell J; Bartosch WJ; Fiore MC; Hasselblad V; Baker T
JAMA; 1997 Dec; 278(21):1759-66. PubMed ID: 9388153
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling.
Fiscella K; Franks P
JAMA; 1996 Apr; 275(16):1247-51. PubMed ID: 8601956
[TBL] [Abstract][Full Text] [Related]
4. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
5. Implementing the Agency for Health Care Policy and Research's Smoking Cessation Guideline in a lung cancer surgery clinic.
Browning KK; Ahijevych KL; Ross P; Wewers ME
Oncol Nurs Forum; 2000 Sep; 27(8):1248-54. PubMed ID: 11013905
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand.
Tosanguan J; Chaiyakunapruk N
Addiction; 2016 Feb; 111(2):340-50. PubMed ID: 26360507
[TBL] [Abstract][Full Text] [Related]
7. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
O'Donnell MP; Roizen MF
Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
[TBL] [Abstract][Full Text] [Related]
8. Projected cost-effectiveness of smoking cessation interventions in patients hospitalized with myocardial infarction.
Ladapo JA; Jaffer FA; Weinstein MC; Froelicher ES
Arch Intern Med; 2011 Jan; 171(1):39-45. PubMed ID: 21220659
[TBL] [Abstract][Full Text] [Related]
9. Determining the cost-effectiveness of a computer-based smoking cessation intervention in primary care.
Smith MY; Cromwell J; DePue J; Spring B; Redd W; Unrod M
Manag Care; 2007 Jul; 16(7):48-55. PubMed ID: 17907712
[TBL] [Abstract][Full Text] [Related]
10. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives.
JAMA; 2000 Jun; 283(24):3244-54. PubMed ID: 10866874
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease.
Berndt N; Bolman C; Lechner L; Max W; Mudde A; de Vries H; Evers S
Eur J Health Econ; 2016 Apr; 17(3):269-85. PubMed ID: 25796578
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.
Cantor SB; Deshmukh AA; Luca NS; Nogueras-González GM; Rajan T; Prokhorov AV
Addict Behav; 2015 Jun; 45():79-86. PubMed ID: 25644592
[TBL] [Abstract][Full Text] [Related]
13. Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment.
Kaper J; Wagena EJ; van Schayck CP; Severens JL
Pharmacoeconomics; 2006; 24(5):453-64. PubMed ID: 16706571
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial.
Ruger JP; Weinstein MC; Hammond SK; Kearney MH; Emmons KM
Value Health; 2008; 11(2):191-8. PubMed ID: 17854434
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling.
Pinget C; Martin E; Wasserfallen JB; Humair JP; Cornuz J
Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):451-5. PubMed ID: 17568248
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of the nicotine transdermal patch for smoking cessation.
Wasley MA; McNagny SE; Phillips VL; Ahluwalia JS
Prev Med; 1997; 26(2):264-70. PubMed ID: 9085397
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison.
Cornuz J; Gilbert A; Pinget C; McDonald P; Slama K; Salto E; Paccaud F
Tob Control; 2006 Jun; 15(3):152-9. PubMed ID: 16728744
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students.
Popp J; Nyman JA; Luo X; Bengtson J; Lust K; An L; Ahluwalia JS; Thomas JL
Eur J Health Econ; 2018 Dec; 19(9):1319-1333. PubMed ID: 29687268
[TBL] [Abstract][Full Text] [Related]
19. Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness.
Solberg LI; Maciosek MV; Edwards NM; Khanchandani HS; Goodman MJ
Am J Prev Med; 2006 Jul; 31(1):62-71. PubMed ID: 16777544
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
